GENERAL CATALOGUE
CDK8-IN-19
HY-176282 · 50 mg
MedChemExpress · Cat: HY-176282
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/cdk8-in-19.htmlCatalog No: HY-176282
Category: Cell Cycle DNA Damage
Pack Size: 50 mg
Brand: MedChemExpress
Description
CDK8-IN-19 Compound 3d is a CDK8 inhibitor with an IC50 of 25.08 nM. CDK8-IN-19 has a broad-spectrum anticancer activity, such as leukemia, melanoma and breast cancer, without significant cytotoxic effect on the normal Vero cells mean IC50s of 2.87, 3.65, 3.79 and 45.48 ?M, respectively .
More from MedChemExpress
TP-061
HY-103041
Cell Cycle DNA Damage
Guttiferone G
HY-N9892
Cell Cycle DNA Damage
C
Cdk14 Mouse Pre-designed siRNA Set A
HY-RS02363
Cell Cycle DNA Damage
HSP70/SIRT2-IN-2
HY-149638
Cell Cycle DNA Damage
Tucidinostat (Standard)
HY-109015R
Cell Cycle DNA Damage
C
CDK2 Human Pre-designed siRNA Set A
HY-RS02374
Cell Cycle DNA Damage
Palmitic acid-d2-1
HY-N0830S11
Cell Cycle DNA Damage
Cdc7-IN-1
HY-101523
Cell Cycle DNA Damage